Ethyl 4,4-difluoro-3-oxobutanoate: A Key Pharmaceutical Intermediate for Advanced Synthesis
Unlock novel drug development with this vital fluorinated building block.
Get a Quote & SampleProduct Core Value
Ethyl 4,4-difluoro-3-oxobutanoate
This compound serves as a critical intermediate in the pharmaceutical industry, enabling the synthesis of advanced therapeutic agents. Its unique difluoro-oxo-butanoate structure makes it invaluable for developing novel drugs targeting various physiological pathways.
- Explore the synthesis of Ethyl 4,4-difluoro-3-oxobutanoate to understand its role in creating complex molecular structures.
- Discover the diverse applications of this CAS 352-24-9 intermediate in pioneering new pharmaceutical treatments.
- Learn about the high purity (99%) available, ensuring reliable results in your drug discovery and development processes.
- Leverage this compound for the creation of potassium channel activators and beta-alanine derived GABA-T antagonists.
Key Advantages
Enhanced Molecular Design
The difluoro substitution in this ethyl 4,4-difluoro-3-oxobutanoate offers unique electronic and steric properties, allowing for sophisticated molecular design in pharmaceutical research.
Streamlined Synthesis Pathways
Utilizing this intermediate can streamline complex organic synthesis routes, reducing reaction steps and increasing overall efficiency for pharmaceutical production.
Foundation for Advanced APIs
As a key building block, it provides a solid foundation for the development of Active Pharmaceutical Ingredients (APIs) with improved efficacy and specificity.
Key Applications
Pharmaceutical Synthesis
This ethyl 4,4-difluoro-3-oxobutanoate is instrumental in creating complex drug molecules. Understanding its buy options and competitive pricing is key for procurement.
Drug Discovery
Its role as a CAS 352-24-9 intermediate makes it a focal point in drug discovery efforts, particularly for neurological and cardiovascular applications.
Custom Synthesis Projects
For specific research needs, engaging in custom synthesis of ethyl 4,4-difluoro-3-oxobutanoate ensures tailored solutions for unique project requirements.
Fluorinated Compound Research
Researchers exploring fluorinated compounds will find this material essential for developing next-generation pharmaceuticals with enhanced properties.